Determining when endoscopic ultrasound changes management for patients with pancreatic cystic neoplasms - 12/04/21
, Safia Maher , Michael S. Bleszynski , Leo Chen , Dave Farnell , Ian Gan , Maja Segedi Abstract Body |
Introduction |
Pancreatic cystic neoplasms (PCNs) are being incidentally detected at an increased rate due to increased CT and MRI usage. EUS is an emerging tool that can differentiate between benign and malignant features of pancreatic cysts. We hoped to identify the specific cross-sectional imaging findings and patient characteristics that warrant EUS referral.
Methods |
We conducted a retrospective case-control chart review, evaluating patients, who were diagnosed with pancreatic cysts and underwent EUS between January 1, 2010 and December 31, 2017.
Results |
EUS was found to change management when CT imaging found cyst size > 4 cm (OR = 4.07, p < 0.01), cyst size > 3 cm (OR = 3.79, p < 0.001) and associated solid component to the cyst (OR = 5.95, p < 0.01). Additionally, patient characteristics, including age less than 50 years, male sex and 10-pack year smoking history were significantly associated with EUS change in management.
Discussion |
Our findings suggest that EUS referral should be coordinated based on the findings of specific HRFs, with support from high risk patient characteristics, rather than the accumulation of multiple HRFs, as suggested by existing guidelines.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Pancreatic cyst size>3 cm is associated with endoscopic ultrasound change in management. |
• | Solid cyst component is associated with endoscopic ultrasound change in management. |
• | Male sex is associated with endoscopic ultrasound change in management. |
• | Smoking history is associated with endoscopic ultrasound change in management. |
Keywords : General surgery, Pancreatic cancer, Gastroenterology, Endoscopic ultrasound, Pancreatic cysts
Plan
Vol 221 - N° 4
P. 813-818 - avril 2021 Retour au numéro
Article précédent
- Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer
- Rebekah Macfie, Cynthia Aks, Kathryn Panwala, Nathalie Johnson
- Travel distance and its interaction with patient and hospital factors in pancreas cancer care
- Julie Siegel, Kathryn E. Engelhardt, Melissa A. Hornor, Katherine A. Morgan, William P. Lancaster
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?